Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1. 2007

Sachie Asada, and Hiroaki Daitoku, and Hitomi Matsuzaki, and Tomoko Saito, and Tatsuhiko Sudo, and Hidehito Mukai, and Shintaro Iwashita, and Koichiro Kako, and Tsutomu Kishi, and Yoshitoshi Kasuya, and Akiyoshi Fukamizu
Center for Tsukuba Advanced Research Alliance, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, Ibaraki 305-8577, Japan.

The members of the transcription factor Foxo family regulate the expression of genes concerned with the stress response, cell cycle and gluconeogenesis. Foxo1 (FKHR) contains 15 consensus phosphorylation sites for the mitogen-activated protein kinase (MAPK) family. Therefore, we hypothesized that MAPKs could directly regulate the transcriptional activity of Foxo1 via phosphorylation. In vitro kinase assay showed that Foxo1 was phosphorylated by extracellular signal-regulated kinase (Erk) and p38 MAPK (p38) but not by c-jun NH2-terminal kinase (JNK). In NIH3T3 cells, epidermal growth factor or anisomycin increased phosphorylation of exogenous Foxo1, which was significantly inhibited by pretreatment with an MEK 1 inhibitor, PD98059, or a p38 inhibitor, SB203580. Two-dimensional phosphopeptide mapping using mutation of phosphorylation sites for MAPK revealed that the nine serine residues in Foxo1 are specifically phosphorylated by Erk and that five of the nine residues are phosphorylated by p38 in vivo. Moreover, we also found that Foxo1 interacts with Ets-1 and functions as a coactivator for Ets-1 on the fetal liver kinase (Flk)-1 promoter in bovine carotid artery endothelial cells. Mutation of the nine phosphorylation sites for Erk in Foxo1 was shown to lead to less binding and synergistic activity for Ets-1 on the Flk-1 promoter when compared with wild-type Foxo1. These results suggest that Foxo1 is specifically phosphorylated by Erk and p38, and that this phosphorylation regulates the function of Foxo1 as a coactivator for Ets-1.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008156 Luciferases Enzymes that oxidize certain LUMINESCENT AGENTS to emit light (PHYSICAL LUMINESCENCE). The luciferases from different organisms have evolved differently so have different structures and substrates. Luciferase
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011500 Protein Synthesis Inhibitors Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. Protein Synthesis Antagonist,Protein Synthesis Antagonists,Protein Synthesis Inhibitor,Antagonist, Protein Synthesis,Antagonists, Protein Synthesis,Inhibitor, Protein Synthesis,Inhibitors, Protein Synthesis,Synthesis Antagonist, Protein,Synthesis Inhibitor, Protein
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D005419 Flavonoids A group of phenyl benzopyrans named for having structures like FLAVONES. 2-Phenyl-Benzopyran,2-Phenyl-Chromene,Bioflavonoid,Bioflavonoids,Flavonoid,2-Phenyl-Benzopyrans,2-Phenyl-Chromenes,2 Phenyl Benzopyran,2 Phenyl Benzopyrans,2 Phenyl Chromene,2 Phenyl Chromenes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Sachie Asada, and Hiroaki Daitoku, and Hitomi Matsuzaki, and Tomoko Saito, and Tatsuhiko Sudo, and Hidehito Mukai, and Shintaro Iwashita, and Koichiro Kako, and Tsutomu Kishi, and Yoshitoshi Kasuya, and Akiyoshi Fukamizu
December 2002, Science (New York, N.Y.),
Sachie Asada, and Hiroaki Daitoku, and Hitomi Matsuzaki, and Tomoko Saito, and Tatsuhiko Sudo, and Hidehito Mukai, and Shintaro Iwashita, and Koichiro Kako, and Tsutomu Kishi, and Yoshitoshi Kasuya, and Akiyoshi Fukamizu
February 2017, Investigative ophthalmology & visual science,
Sachie Asada, and Hiroaki Daitoku, and Hitomi Matsuzaki, and Tomoko Saito, and Tatsuhiko Sudo, and Hidehito Mukai, and Shintaro Iwashita, and Koichiro Kako, and Tsutomu Kishi, and Yoshitoshi Kasuya, and Akiyoshi Fukamizu
January 2016, PloS one,
Sachie Asada, and Hiroaki Daitoku, and Hitomi Matsuzaki, and Tomoko Saito, and Tatsuhiko Sudo, and Hidehito Mukai, and Shintaro Iwashita, and Koichiro Kako, and Tsutomu Kishi, and Yoshitoshi Kasuya, and Akiyoshi Fukamizu
May 2000, Cellular and molecular biology (Noisy-le-Grand, France),
Sachie Asada, and Hiroaki Daitoku, and Hitomi Matsuzaki, and Tomoko Saito, and Tatsuhiko Sudo, and Hidehito Mukai, and Shintaro Iwashita, and Koichiro Kako, and Tsutomu Kishi, and Yoshitoshi Kasuya, and Akiyoshi Fukamizu
February 2004, Journal of neuroendocrinology,
Sachie Asada, and Hiroaki Daitoku, and Hitomi Matsuzaki, and Tomoko Saito, and Tatsuhiko Sudo, and Hidehito Mukai, and Shintaro Iwashita, and Koichiro Kako, and Tsutomu Kishi, and Yoshitoshi Kasuya, and Akiyoshi Fukamizu
January 2000, Methods in enzymology,
Sachie Asada, and Hiroaki Daitoku, and Hitomi Matsuzaki, and Tomoko Saito, and Tatsuhiko Sudo, and Hidehito Mukai, and Shintaro Iwashita, and Koichiro Kako, and Tsutomu Kishi, and Yoshitoshi Kasuya, and Akiyoshi Fukamizu
August 1998, Circulation research,
Sachie Asada, and Hiroaki Daitoku, and Hitomi Matsuzaki, and Tomoko Saito, and Tatsuhiko Sudo, and Hidehito Mukai, and Shintaro Iwashita, and Koichiro Kako, and Tsutomu Kishi, and Yoshitoshi Kasuya, and Akiyoshi Fukamizu
May 2004, The Journal of biological chemistry,
Sachie Asada, and Hiroaki Daitoku, and Hitomi Matsuzaki, and Tomoko Saito, and Tatsuhiko Sudo, and Hidehito Mukai, and Shintaro Iwashita, and Koichiro Kako, and Tsutomu Kishi, and Yoshitoshi Kasuya, and Akiyoshi Fukamizu
March 2024, The Plant cell,
Sachie Asada, and Hiroaki Daitoku, and Hitomi Matsuzaki, and Tomoko Saito, and Tatsuhiko Sudo, and Hidehito Mukai, and Shintaro Iwashita, and Koichiro Kako, and Tsutomu Kishi, and Yoshitoshi Kasuya, and Akiyoshi Fukamizu
January 2005, Anticancer research,
Copied contents to your clipboard!